SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '541'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_C_TRPC81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 1gtnB-1knrA:undetectable1gtnC-1knrA:undetectable | 1gtnB-1knrA:9.071gtnC-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_I_TRPI81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.14A | 1gtnH-1knrA:undetectable1gtnI-1knrA:undetectable | 1gtnH-1knrA:9.071gtnI-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_O_TRPO81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 1gtnO-1knrA:undetectable1gtnP-1knrA:undetectable | 1gtnO-1knrA:9.071gtnP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_O_TRPO81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264THR A 119THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.24A | 1gtnO-1knrA:undetectable1gtnP-1knrA:undetectable | 1gtnO-1knrA:9.071gtnP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_Q_TRPQ81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 9 | GLY A 264THR A 119THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.22A | 1gtnQ-1knrA:undetectable1gtnR-1knrA:undetectable | 1gtnQ-1knrA:9.071gtnR-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_U_TRPU81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.15A | 1gtnU-1knrA:undetectable1gtnV-1knrA:undetectable | 1gtnU-1knrA:9.071gtnV-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HXB_A_ROCA100_4 (HIV-1 PROTEASE) |
2vl7 | XPD (Sulfurisphaeratokodaii) | 4 / 4 | GLY A 75ASP A 146GLY A 47THR A 40 | NoneNoneNonePO4 A1541 ( 4.8A) | 0.81A | 1hxbB-2vl7A:undetectable | 1hxbB-2vl7A:11.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MX1_E_THAE5_1 (LIVERCARBOXYLESTERASE I) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 5 / 12 | LEU A 68GLY A 203VAL A 202LEU A 540LEU A 521 | FAD A 541 (-4.1A)FAD A 541 ( 3.7A)NoneNoneNone | 1.45A | 1mx1E-3js8A:undetectable | 1mx1E-3js8A:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NBH_A_SAMA293_1 (GLYCINEN-METHYLTRANSFERASE) |
2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) | 3 / 3 | ARG A 643ASP A 900ASN A1027 | NoneGOL A1541 (-3.5A)None | 0.93A | 1nbhA-2x2iA:undetectable | 1nbhA-2x2iA:14.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NBH_D_SAMD3293_1 (GLYCINEN-METHYLTRANSFERASE) |
2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) | 3 / 3 | ARG A 643ASP A 900ASN A1027 | NoneGOL A1541 (-3.5A)None | 0.92A | 1nbhD-2x2iA:undetectable | 1nbhD-2x2iA:14.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ONI_I_BEZI518_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
5gpr | CHITINASE (Ostriniafurnacalis) | 4 / 7 | ILE A 541GLY A 539ASN A 176ASN A 142 | ILE A 541 ( 0.7A)GLY A 539 ( 0.0A)ASN A 176 ( 0.6A)ASN A 142 ( 0.6A) | 1.01A | 1oniG-5gprA:undetectable1oniI-5gprA:0.8 | 1oniG-5gprA:14.231oniI-5gprA:14.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OS2_A_HAEA874_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.28A | 1os2A-2fv5A:9.5 | 1os2A-2fv5A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OS2_D_HAED574_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.25A | 1os2D-2fv5A:9.6 | 1os2D-2fv5A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R55_A_097A518_1 (ADAM 33) |
2fv5 | ADAM 17 (Homosapiens) | 5 / 10 | THR A 347HIS A 405GLU A 406HIS A 409ALA A 439 | 541 A 1 (-3.6A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A)541 A 1 (-3.9A) | 1.04A | 1r55A-2fv5A:21.3 | 1r55A-2fv5A:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R55_A_097A518_1 (ADAM 33) |
2fv5 | ADAM 17 (Homosapiens) | 5 / 10 | THR A 347HIS A 405GLU A 406HIS A 409HIS A 415 | 541 A 1 (-3.6A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.28A | 1r55A-2fv5A:21.3 | 1r55A-2fv5A:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG9_A_SAMA385_0 (S-ADENOSYLMETHIONINESYNTHETASE) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 4 / 8 | HIS A 244PRO A 245SER A 389THR A 119 | CL A 541 (-4.8A)NoneFAD A 800 (-4.3A)None | 1.21A | 1rg9A-1knrA:undetectable | 1rg9A-1knrA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG9_B_SAMB485_1 (S-ADENOSYLMETHIONINESYNTHETASE) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 4 / 8 | HIS A 244PRO A 245SER A 389THR A 119 | CL A 541 (-4.8A)NoneFAD A 800 (-4.3A)None | 1.21A | 1rg9B-1knrA:undetectable | 1rg9B-1knrA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG9_C_SAMC685_1 (S-ADENOSYLMETHIONINESYNTHETASE) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 4 / 8 | HIS A 244PRO A 245SER A 389THR A 119 | CL A 541 (-4.8A)NoneFAD A 800 (-4.3A)None | 1.22A | 1rg9D-1knrA:undetectable | 1rg9D-1knrA:20.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TUF_B_AZ1B503_1 (DIAMINOPIMELATEDECARBOXYLASE) |
1ko0 | DIAMINOPIMELATEDECARBOXYLASE (Escherichiacoli) | 4 / 6 | ARG A 271ARG A 307TYR A 311TYR A 378 | LYS A 541 ( 3.3A)LYS A 541 (-4.0A)LYS A 541 ( 4.4A)LYS A 541 (-3.4A) | 0.88A | 1tufA-1ko0A:42.01tufB-1ko0A:42.4 | 1tufA-1ko0A:32.051tufB-1ko0A:32.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1U72_A_MTXA188_1 (DIHYDROFOLATEREDUCTASE) |
1yt8 | THIOSULFATESULFURTRANSFERASE (Pseudomonasaeruginosa) | 5 / 12 | ALA A 446LEU A 442GLN A 419PRO A 47LEU A 75 | NoneNoneNoneGOL A 541 (-4.6A)None | 1.31A | 1u72A-1yt8A:undetectable | 1u72A-1yt8A:15.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_T_TRPT81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.17A | 1utdT-1knrA:undetectable1utdU-1knrA:undetectable | 1utdT-1knrA:9.071utdU-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_T_TRPT81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264THR A 119THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 1utdT-1knrA:undetectable1utdU-1knrA:undetectable | 1utdT-1knrA:9.071utdU-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTT_A_HAEA1265_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.28A | 1uttA-2fv5A:10.0 | 1uttA-2fv5A:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTZ_A_HAEA1267_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.29A | 1utzA-2fv5A:9.8 | 1utzA-2fv5A:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTZ_B_HAEB1266_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.28A | 1utzB-2fv5A:9.8 | 1utzB-2fv5A:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y93_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 6 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.26A | 1y93A-2fv5A:9.8 | 1y93A-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FK8_A_SAMA302_0 (METHOXY MYCOLIC ACIDSYNTHASE 4) |
3gwf | CYCLOHEXANONEMONOOXYGENASE (Rhodococcussp.HI-31) | 5 / 12 | THR A 47TYR A 49ILE A 14GLY A 15GLY A 17 | FAD A 541 (-3.7A)NoneFAD A 541 (-4.8A)FAD A 541 (-3.3A)FAD A 541 (-3.4A) | 0.98A | 2fk8A-3gwfA:undetectable | 2fk8A-3gwfA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HU6_A_HAEA269_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.22A | 2hu6A-2fv5A:9.9 | 2hu6A-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JIH_A_097A1001_1 (ADAMTS-1) |
2fv5 | ADAM 17 (Homosapiens) | 5 / 9 | LEU A 348HIS A 405GLU A 406HIS A 409HIS A 415 | 541 A 1 (-4.4A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.29A | 2jihA-2fv5A:20.4 | 2jihA-2fv5A:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JIH_B_097B1001_1 (ADAMTS-1) |
2fv5 | ADAM 17 (Homosapiens) | 5 / 8 | LEU A 348HIS A 405GLU A 406HIS A 409HIS A 415 | 541 A 1 (-4.4A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.23A | 2jihB-2fv5A:20.6 | 2jihB-2fv5A:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JN3_A_JN3A130_2 (FATTY ACID-BINDINGPROTEIN, LIVER) |
2vl7 | XPD (Sulfurisphaeratokodaii) | 4 / 7 | LEU A 388LEU A 456PRO A 35ARG A 507 | NoneNonePO4 A1541 (-4.4A)None | 1.00A | 2jn3A-2vl7A:undetectable | 2jn3A-2vl7A:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNH_A_9CRA501_1 (CYTOCHROME P450 2C8) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 5 / 11 | GLY A 247SER A 252SER A 227ALA A 348ILE A 456 | ATP A 541 (-3.1A)NoneNoneNoneNone | 0.95A | 2nnhA-1ytmA:undetectable | 2nnhA-1ytmA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OKC_B_SAMB500_0 (TYPE I RESTRICTIONENZYME STYSJI MPROTEIN) |
5c05 | PUTATIVEGAMMA-TERPINENESYNTHASE (Thymusvulgaris) | 5 / 12 | ALA A 543ASN A 541VAL A 206ASN A 480ARG A 564 | ALA A 543 ( 0.0A)ASN A 541 (-0.6A)VAL A 206 ( 0.6A)ASN A 480 ( 0.6A)ARG A 564 ( 0.6A) | 1.12A | 2okcB-5c05A:undetectable | 2okcB-5c05A:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_A_HAEA502_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 6 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.33A | 2ow9A-2fv5A:9.6 | 2ow9A-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_B_HAEB502_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.32A | 2ow9B-2fv5A:9.5 | 2ow9B-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_C_HAEC3001_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.34A | 2ozrC-2fv5A:9.2 | 2ozrC-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_D_HAED3002_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.31A | 2ozrD-2fv5A:9.3 | 2ozrD-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_E_HAEE3003_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.31A | 2ozrE-2fv5A:9.4 | 2ozrE-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QEO_B_LNRB200_1 (D7R4 PROTEIN) |
1yt8 | THIOSULFATESULFURTRANSFERASE (Pseudomonasaeruginosa) | 5 / 10 | GLU A 313ARG A 154HIS A 316GLU A 495ASP A 156 | NoneNoneGOL A 541 (-3.7A)NoneNone | 1.23A | 2qeoB-1yt8A:0.0 | 2qeoB-1yt8A:10.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RK8_A_PPFA3969_1 (PHOSPHOENOLPYRUVATECARBOXYKINASE,CYTOSOLIC [GTP]) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 7 / 8 | ARG A 60LYS A 205LYS A 206HIS A 225SER A 244ASP A 263ARG A 327 | OXD A 543 (-4.1A)OXD A 543 ( 4.2A) MN A 999 ( 2.4A) MN A 999 (-3.4A)OXD A 543 ( 2.3A) MN A 999 (-2.5A)ATP A 541 ( 2.8A) | 0.70A | 2rk8A-1ytmA:30.7 | 2rk8A-1ytmA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RK8_B_PPFB3969_1 (PHOSPHOENOLPYRUVATECARBOXYKINASE,CYTOSOLIC [GTP]) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 7 / 7 | ARG A 60LYS A 205LYS A 206HIS A 225SER A 244ASP A 263ARG A 327 | OXD A 543 (-4.1A)OXD A 543 ( 4.2A) MN A 999 ( 2.4A) MN A 999 (-3.4A)OXD A 543 ( 2.3A) MN A 999 (-2.5A)ATP A 541 ( 2.8A) | 0.73A | 2rk8B-1ytmA:29.2 | 2rk8B-1ytmA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DH0_A_SAMA220_1 (SAM DEPENDENTMETHYLTRANSFERASE) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 4 / 8 | ASP A 134GLN A 50MET A 327GLU A 121 | NoneNoneNone CL A 541 ( 4.2A) | 1.37A | 3dh0A-1knrA:2.4 | 3dh0A-1knrA:17.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3F8W_B_ADNB301_1 (PURINE-NUCLEOSIDEPHOSPHORYLASE) |
3sql | GLYCOSYL HYDROLASEFAMILY 3 (Synechococcussp.PCC7002) | 5 / 12 | SER A 204GLY A 198GLY A 196ASN A 156VAL A 158 | ACY A 541 ( 3.8A)NoneNoneNoneNone | 1.30A | 3f8wB-3sqlA:undetectable | 3f8wB-3sqlA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HY7_A_097A801_1 (A DISINTEGRIN ANDMETALLOPROTEINASEWITH THROMBOSPONDINMOTIFS 5) |
2fv5 | ADAM 17 (Homosapiens) | 6 / 9 | LEU A 348HIS A 405GLU A 406HIS A 409HIS A 415ILE A 438 | 541 A 1 (-4.4A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A)None | 0.43A | 3hy7A-2fv5A:20.0 | 3hy7A-2fv5A:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HY7_B_097B801_1 (A DISINTEGRIN ANDMETALLOPROTEINASEWITH THROMBOSPONDINMOTIFS 5) |
2fv5 | ADAM 17 (Homosapiens) | 6 / 9 | LEU A 348HIS A 405GLU A 406HIS A 409HIS A 415ILE A 438 | 541 A 1 (-4.4A) ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A)None | 0.37A | 3hy7B-2fv5A:20.0 | 3hy7B-2fv5A:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEC_A_HAEA272_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.29A | 3kecA-2fv5A:9.7 | 3kecA-2fv5A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LIK_A_HAEA302_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.27A | 3likA-2fv5A:9.9 | 3likA-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LIL_A_HAEA302_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.28A | 3lilA-2fv5A:9.8 | 3lilA-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LJG_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.26A | 3ljgA-2fv5A:10.0 | 3ljgA-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LKA_A_HAEA269_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.24A | 3lkaA-2fv5A:9.9 | 3lkaA-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_2 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 3 / 3 | SER A 531SER A 532HIS A 201 | NoneNoneFAD A 541 (-4.2A) | 0.82A | 3mzeA-3js8A:undetectable | 3mzeA-3js8A:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O9M_B_BEZB999_0 (CHOLINESTERASE) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 4 / 6 | GLY A 137GLY A 136LEU A 171HIS A 201 | FAD A 541 (-3.4A)FAD A 541 (-3.8A)NoneFAD A 541 (-4.2A) | 0.77A | 3o9mB-3js8A:undetectable | 3o9mB-3js8A:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_A_RBVA601_1 (RNA POLYMERASE) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 5 / 9 | ASP A 541ASN A 613GLY A 667ASP A 668ASP A 669 | ASP A 541 ( 0.6A)ASN A 613 ( 0.6A)GLY A 667 ( 0.0A)ASP A 668 ( 0.6A)ASP A 669 ( 0.6A) | 1.06A | 3sfuA-4mtpA:19.2 | 3sfuA-4mtpA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_A_RBVA601_1 (RNA POLYMERASE) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 5 / 9 | ASP A 541SER A 604ASN A 613GLY A 667ASP A 668 | ASP A 541 ( 0.6A)SER A 604 ( 0.0A)ASN A 613 ( 0.6A)GLY A 667 ( 0.0A)ASP A 668 ( 0.6A) | 1.04A | 3sfuA-4mtpA:19.2 | 3sfuA-4mtpA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_B_RBVB601_1 (RNA POLYMERASE) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 5 / 9 | ASP A 541ASN A 613GLY A 667ASP A 668ASP A 669 | ASP A 541 ( 0.6A)ASN A 613 ( 0.6A)GLY A 667 ( 0.0A)ASP A 668 ( 0.6A)ASP A 669 ( 0.6A) | 1.01A | 3sfuB-4mtpA:21.6 | 3sfuB-4mtpA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_C_RBVC601_1 (RNA POLYMERASE) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 5 / 11 | ASP A 541SER A 604ASN A 613GLY A 667ASP A 668 | ASP A 541 ( 0.6A)SER A 604 ( 0.0A)ASN A 613 ( 0.6A)GLY A 667 ( 0.0A)ASP A 668 ( 0.6A) | 1.04A | 3sfuC-4mtpA:19.6 | 3sfuC-4mtpA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SFU_C_RBVC601_1 (RNA POLYMERASE) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 5 / 11 | ASP A 541SER A 604THR A 609ASN A 613GLY A 667 | ASP A 541 ( 0.6A)SER A 604 ( 0.0A)THR A 609 ( 0.8A)ASN A 613 ( 0.6A)GLY A 667 ( 0.0A) | 1.11A | 3sfuC-4mtpA:19.6 | 3sfuC-4mtpA:22.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_A_W9TA1001_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.86A | 3w9tA-3ke6A:undetectable | 3w9tA-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_A_W9TA1001_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.08A | 3w9tA-3ke6A:undetectable | 3w9tA-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_B_W9TB503_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.87A | 3w9tB-3ke6A:undetectable | 3w9tB-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_B_W9TB503_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.08A | 3w9tB-3ke6A:undetectable | 3w9tB-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_C_W9TC1001_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.86A | 3w9tC-3ke6A:undetectable | 3w9tC-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_C_W9TC1001_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.09A | 3w9tC-3ke6A:undetectable | 3w9tC-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_D_W9TD502_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.86A | 3w9tD-3ke6A:undetectable | 3w9tD-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_D_W9TD502_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.07A | 3w9tD-3ke6A:undetectable | 3w9tD-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_E_W9TE504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.86A | 3w9tE-3ke6A:undetectable | 3w9tE-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_E_W9TE504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.07A | 3w9tE-3ke6A:undetectable | 3w9tE-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_F_W9TF504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.87A | 3w9tF-3ke6A:undetectable | 3w9tF-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_F_W9TF504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.09A | 3w9tF-3ke6A:undetectable | 3w9tF-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_G_W9TG504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 387 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)None MN A 2 (-2.6A) | 0.86A | 3w9tG-3ke6A:undetectable | 3w9tG-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_G_W9TG504_1 (HEMOLYTIC LECTINCEL-III) |
3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) | 4 / 5 | ASP A 211VAL A 213GLY A 214ASP A 388 | MN A 2 ( 2.5A) MN A 541 ( 4.7A)NoneNone | 1.07A | 3w9tG-3ke6A:undetectable | 3w9tG-3ke6A:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7B_A_HAEA1273_1 (COLLAGENASE 3) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 6 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.41A | 4a7bA-2fv5A:9.3 | 4a7bA-2fv5A:23.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_B_SAMB1281_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 5 / 12 | LYS A 206GLY A 242GLY A 404LEU A 251ASP A 263 | MN A 999 ( 2.4A)NoneNoneATP A 541 ( 4.5A) MN A 999 (-2.5A) | 1.13A | 4blvB-1ytmA:undetectable | 4blvB-1ytmA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FFW_B_715B801_1 (DIPEPTIDYL PEPTIDASE4) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 12 | ARG A 290GLU A 260GLU A 121GLY A 123HIS A 351 | CL A 541 ( 4.6A)None CL A 541 ( 4.2A)NoneFAD A 800 (-4.2A) | 1.37A | 4ffwB-1knrA:undetectable | 4ffwB-1knrA:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GC9_A_ACTA402_0 (DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL) |
3pqs | TRANSFERRIN-BINDINGPROTEIN (Actinobacilluspleuropneumoniae) | 3 / 3 | LYS A 523TYR A 397ARG A 524 | NoneNoneGOL A 541 ( 3.9A) | 1.35A | 4gc9A-3pqsA:undetectable | 4gc9A-3pqsA:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GH8_B_MTXB201_1 (DIHYDROFOLATEREDUCTASE) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 5 / 12 | ILE A 141ALA A 200LEU A 540ILE A 500PRO A 501 | FAD A 541 (-4.5A)NoneNoneNoneNone | 1.29A | 4gh8B-3js8A:undetectable | 4gh8B-3js8A:14.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LV9_A_20JA602_1 (NICOTINAMIDEPHOSPHORIBOSYLTRANSFERASE) |
3gwf | CYCLOHEXANONEMONOOXYGENASE (Rhodococcussp.HI-31) | 4 / 7 | VAL A 143ILE A 392ILE A 394ALA A 115 | FAD A 541 (-3.8A)FAD A 541 (-4.5A)NoneNone | 0.78A | 4lv9A-3gwfA:undetectable | 4lv9A-3gwfA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKV_A_AERA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 5 / 12 | LEU A 251ARG A 450GLY A 451VAL A 433VAL A 365 | ATP A 541 ( 4.5A)NoneNoneNoneNone | 0.97A | 4nkvA-1ytmA:undetectable | 4nkvA-1ytmA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_C_SAMC601_0 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
3gwf | CYCLOHEXANONEMONOOXYGENASE (Rhodococcussp.HI-31) | 5 / 12 | ASN A 51GLY A 190SER A 188ILE A 184GLY A 182 | FAD A 541 (-4.1A)NoneNAP A 542 (-2.9A)NAP A 542 (-4.7A)None | 1.21A | 4obwC-3gwfA:2.5 | 4obwC-3gwfA:17.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QZT_A_RTLA201_1 (RETINOL-BINDINGPROTEIN 2) |
1ytm | PHOSPHOENOLPYRUVATECARBOXYKINASE [ATP] (Anaerobiospirillumsucciniciproducens) | 3 / 3 | PHE A 511THR A 246LEU A 432 | NoneATP A 541 (-4.8A)None | 0.72A | 4qztA-1ytmA:undetectable | 4qztA-1ytmA:14.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UDA_A_DEXA1985_2 (MINERALOCORTICOIDRECEPTOR) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 6 | LEU A 251PHE A 338THR A 385VAL A 402 | NoneNoneNone541 A 1 ( 4.1A) | 1.09A | 4udaA-2fv5A:undetectable | 4udaA-2fv5A:24.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YO9_B_ACTB401_0 (3C-LIKE PROTEINASE) |
3t63 | PROTOCATECHUATE3,4-DIOXYGENASE BETACHAIN (Pseudomonasputida) | 3 / 3 | ARG M 522ASP M 524TYR M 436 | NoneGOL M 541 (-4.5A)None | 0.93A | 4yo9B-3t63M:undetectable | 4yo9B-3t63M:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ALB_L_TIQL1210_2 (MEDI2452 LIGHT CHAIN) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 4 / 8 | SER A 163GLY A 143ALA A 106GLY A 137 | NoneFAD A 541 (-3.2A)FAD A 541 (-3.3A)FAD A 541 (-3.4A) | 0.88A | 5albL-3js8A:undetectable | 5albL-3js8A:18.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eeuF-1knrA:undetectable5eeuG-1knrA:0.0 | 5eeuF-1knrA:9.075eeuG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eeuO-1knrA:undetectable5eeuP-1knrA:undetectable | 5eeuO-1knrA:9.075eeuP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.18A | 5eeuQ-1knrA:undetectable5eeuR-1knrA:undetectable | 5eeuQ-1knrA:9.075eeuR-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eevF-1knrA:undetectable5eevG-1knrA:0.0 | 5eevF-1knrA:9.075eevG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eevO-1knrA:undetectable5eevP-1knrA:undetectable | 5eevO-1knrA:9.075eevP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eevQ-1knrA:undetectable5eevR-1knrA:undetectable | 5eevQ-1knrA:9.075eevR-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eewF-1knrA:undetectable5eewG-1knrA:0.0 | 5eewF-1knrA:9.075eewG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eewO-1knrA:undetectable5eewP-1knrA:undetectable | 5eewO-1knrA:9.075eewP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eewQ-1knrA:undetectable5eewR-1knrA:undetectable | 5eewQ-1knrA:9.075eewR-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eexF-1knrA:undetectable5eexG-1knrA:0.0 | 5eexF-1knrA:9.075eexG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eexO-1knrA:undetectable5eexP-1knrA:undetectable | 5eexO-1knrA:9.075eexP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eeyF-1knrA:undetectable5eeyG-1knrA:0.0 | 5eeyF-1knrA:9.075eeyG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eeyO-1knrA:undetectable5eeyP-1knrA:undetectable | 5eeyO-1knrA:9.075eeyP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5eezF-1knrA:undetectable5eezG-1knrA:0.0 | 5eezF-1knrA:9.075eezG-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5eezO-1knrA:undetectable5eezP-1knrA:undetectable | 5eezO-1knrA:9.075eezP-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5ef0F-1knrA:undetectable5ef0G-1knrA:0.0 | 5ef0F-1knrA:9.075ef0G-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5ef0O-1knrA:undetectable5ef0P-1knrA:undetectable | 5ef0O-1knrA:9.075ef0P-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.14A | 5ef1F-1knrA:undetectable5ef1G-1knrA:0.0 | 5ef1F-1knrA:9.075ef1G-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5ef1O-1knrA:undetectable5ef1P-1knrA:undetectable | 5ef1O-1knrA:9.075ef1P-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5ef2F-1knrA:undetectable5ef2G-1knrA:0.0 | 5ef2F-1knrA:9.075ef2G-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.19A | 5ef2O-1knrA:undetectable5ef2P-1knrA:undetectable | 5ef2O-1knrA:9.075ef2P-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_F_TRPF101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | THR A 259SER A 389ALA A 388GLY A 264THR A 119 | CL A 541 (-3.9A)FAD A 800 (-4.3A)NoneNoneNone | 1.13A | 5ef3F-1knrA:undetectable5ef3G-1knrA:0.0 | 5ef3F-1knrA:9.075ef3G-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_P_TRPP101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | GLY A 264HIS A 131THR A 259SER A 389ALA A 388 | NoneNone CL A 541 (-3.9A)FAD A 800 (-4.3A)None | 1.20A | 5ef3O-1knrA:undetectable5ef3P-1knrA:undetectable | 5ef3O-1knrA:9.075ef3P-1knrA:9.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KF8_A_GCSA404_1 (PREDICTEDACETYLTRANSFERASE) |
2vl7 | XPD (Sulfurisphaeratokodaii) | 4 / 8 | TRP A 11GLU A 345PRO A 509GLY A 36 | NoneNoneNonePO4 A1541 (-4.0A) | 1.13A | 5kf8A-2vl7A:undetectable | 5kf8A-2vl7A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KGP_A_GCSA407_1 (PREDICTEDACETYLTRANSFERASE) |
2vl7 | XPD (Sulfurisphaeratokodaii) | 4 / 8 | TRP A 11GLU A 345PRO A 509GLY A 36 | NoneNoneNonePO4 A1541 (-4.0A) | 1.13A | 5kgpA-2vl7A:undetectable | 5kgpA-2vl7A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KGP_B_GCSB405_1 (PREDICTEDACETYLTRANSFERASE) |
2vl7 | XPD (Sulfurisphaeratokodaii) | 4 / 8 | TRP A 11GLU A 345PRO A 509GLY A 36 | NoneNoneNonePO4 A1541 (-4.0A) | 1.12A | 5kgpB-2vl7A:undetectable | 5kgpB-2vl7A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LG3_A_Z80A401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 5 / 11 | ILE A 195PHE A 188VAL A 168ILE A 207ALA A 173 | NoneNoneNoneFAD A 541 (-4.4A)None | 1.13A | 5lg3A-3js8A:undetectable | 5lg3A-3js8A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LG3_E_Z80E401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 5 / 12 | ILE A 195PHE A 188VAL A 168ILE A 207ALA A 173 | NoneNoneNoneFAD A 541 (-4.4A)None | 1.09A | 5lg3E-3js8A:undetectable | 5lg3E-3js8A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5J_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 4 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.25A | 5n5jA-2fv5A:10.0 | 5n5jA-2fv5A:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5K_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
2fv5 | ADAM 17 (Homosapiens) | 4 / 5 | HIS A 405GLU A 406HIS A 409HIS A 415 | ZN A 3 ( 3.2A)541 A 1 (-2.6A) ZN A 3 ( 3.3A) ZN A 3 ( 3.2A) | 0.25A | 5n5kA-2fv5A:10.0 | 5n5kA-2fv5A:24.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NWW_A_ACAA18_2 (SCRFP-TAG,GP41) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 3 / 3 | LYS A 480TRP A 490SER A 479 | NoneNoneFAD A 541 ( 4.0A) | 1.05A | 5nwwA-3js8A:undetectable | 5nwwA-3js8A:6.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NZW_A_9F2A1102_1 (DNA CROSS-LINKREPAIR 1A PROTEIN) |
2bib | TEICHOIC ACIDPHOSPHORYLCHOLINEESTERASE/ CHOLINEBINDING PROTEIN (Streptococcuspneumoniae) | 5 / 10 | HIS A 85HIS A 87HIS A 90ASP A 203HIS A 228 | ZN A1550 (-3.3A) ZN A1550 ( 3.1A) ZN A1549 (-3.2A) ZN A1549 (-2.3A) PC A1541 (-3.9A) | 0.71A | 5nzwA-2bibA:7.4 | 5nzwA-2bibA:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B89_A_NOVA403_1 (LIPOPOLYSACCHARIDEEXPORT SYSTEMATP-BINDING PROTEINLPTB) |
1knr | L-ASPARTATE OXIDASE (Escherichiacoli) | 5 / 10 | LEU A 257HIS A 244ALA A 247PRO A 217SER A 220 | FAD A 800 (-4.3A) CL A 541 (-4.8A)NoneNoneNone | 1.50A | 6b89A-1knrA:undetectable | 6b89A-1knrA:10.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DYO_A_LDPA901_0 (EBONY) |
3js8 | CHOLESTEROL OXIDASE (Chromobacteriumsp.DS-1) | 4 / 5 | VAL A 42LEU A 206HIS A 201THR A 84 | NoneFAD A 541 (-4.8A)FAD A 541 (-4.2A)FAD A 541 ( 4.5A) | 1.30A | 6dyoA-3js8A:undetectable | 6dyoA-3js8A:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_A_TKTA508_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
2hr7 | INSULIN RECEPTOR (Homosapiens) | 4 / 8 | ASP A 132ILE A 136ARG A 181ASN A 108 | NoneNoneGOL A 595 (-3.3A)NAG A 541 (-3.6A) | 1.21A | 6hisA-2hr7A:undetectable6hisB-2hr7A:undetectable | 6hisA-2hr7A:10.696hisB-2hr7A:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_B_TKTB508_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
2hr7 | INSULIN RECEPTOR (Homosapiens) | 4 / 8 | ASP A 132ILE A 136ARG A 181ASN A 108 | NoneNoneGOL A 595 (-3.3A)NAG A 541 (-3.6A) | 1.22A | 6hisB-2hr7A:undetectable6hisC-2hr7A:undetectable | 6hisB-2hr7A:10.696hisC-2hr7A:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_C_TKTC508_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
2hr7 | INSULIN RECEPTOR (Homosapiens) | 4 / 8 | ASP A 132ILE A 136ARG A 181ASN A 108 | NoneNoneGOL A 595 (-3.3A)NAG A 541 (-3.6A) | 1.22A | 6hisC-2hr7A:undetectable6hisD-2hr7A:undetectable | 6hisC-2hr7A:10.696hisD-2hr7A:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_D_TKTD501_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
2hr7 | INSULIN RECEPTOR (Homosapiens) | 4 / 8 | ASP A 132ILE A 136ARG A 181ASN A 108 | NoneNoneGOL A 595 (-3.3A)NAG A 541 (-3.6A) | 1.21A | 6hisD-2hr7A:undetectable6hisE-2hr7A:undetectable | 6hisD-2hr7A:10.696hisE-2hr7A:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_E_TKTE501_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
2hr7 | INSULIN RECEPTOR (Homosapiens) | 4 / 8 | ASN A 108ASP A 132ILE A 136ARG A 181 | NAG A 541 (-3.6A)NoneNoneGOL A 595 (-3.3A) | 1.23A | 6hisA-2hr7A:undetectable6hisE-2hr7A:undetectable | 6hisA-2hr7A:10.696hisE-2hr7A:10.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HLO_A_GBQA1501_0 (SUBSTANCE-PRECEPTOR,GLGAGLYCOGENSYNTHASE,SUBSTANCE-PRECEPTOR) |
1v0f | ENDO-ALPHA-SIALIDASE (EnterobacteriaphageK1F) | 5 / 12 | PRO A 548ILE A 571TYR A 541HIS A 542THR A 524 | PRO A 548 ( 1.1A)ILE A 571 ( 0.7A)TYR A 541 ( 1.3A)HIS A 542 ( 1.0A)THR A 524 ( 0.9A) | 1.29A | 6hloA-1v0fA:0.0 | 6hloA-1v0fA:21.46 |